Development and validation of a GC-FID assay for determination of fluvastatin in pharmaceutical preparations

A gas chromatographic method has been developed for the assay of fluvastatin sodium (FLU). FLU was silylated with N,O-bis(trimethylsilyl)trifluoroacetamide-1% trimethylchlorosilane at 90 ºC for 30 min and analysed in a DB-1 column by capillary gas chromatograph with a flame ionization detector. The...

Full description

Bibliographic Details
Main Authors: Serap Saglik Aslan, Olcay Sagirli and Lale Ersoy
Format: Article
Language:English
Published: Sociedade Brasileira de Química 2009-01-01
Series:Química Nova
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422009000900021
id doaj-baa3396cf59844d1b490aa53fe1fdb79
record_format Article
spelling doaj-baa3396cf59844d1b490aa53fe1fdb792020-11-24T23:57:21ZengSociedade Brasileira de QuímicaQuímica Nova0100-40421678-70642009-01-013292347235010.1590/S0100-40422009000900021Development and validation of a GC-FID assay for determination of fluvastatin in pharmaceutical preparationsSerap Saglik AslanOlcay Sagirli and Lale ErsoyA gas chromatographic method has been developed for the assay of fluvastatin sodium (FLU). FLU was silylated with N,O-bis(trimethylsilyl)trifluoroacetamide-1% trimethylchlorosilane at 90 ºC for 30 min and analysed in a DB-1 column by capillary gas chromatograph with a flame ionization detector. The method was validated. The assay was linear over the concentration range at 10.0 to 50.0 µg mL-1. The limit of detection and the limit of quantitation were 1.0 and 3.0 µg mL-1, respectively. The recoveries of FLU derivatives were in the range of 99.25-99.80%. In inter-day and intra-day analysis, the values of relative standard deviation (%) and the relative mean error (%) were found between 0.20-0.80% and -0.20-0.75%, respectively. The developed method was succesfully applied to analyze the FLU content in tablet formulation. The results were statistically compared with those obtained by the official method, and no significant difference was found between the two methods. Therefore, it can be recommended for the quality control assay of FLU in pharmaceutical industry.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422009000900021fluvastatinvalidationpharmaceutical preparations
collection DOAJ
language English
format Article
sources DOAJ
author Serap Saglik Aslan
Olcay Sagirli and Lale Ersoy
spellingShingle Serap Saglik Aslan
Olcay Sagirli and Lale Ersoy
Development and validation of a GC-FID assay for determination of fluvastatin in pharmaceutical preparations
Química Nova
fluvastatin
validation
pharmaceutical preparations
author_facet Serap Saglik Aslan
Olcay Sagirli and Lale Ersoy
author_sort Serap Saglik Aslan
title Development and validation of a GC-FID assay for determination of fluvastatin in pharmaceutical preparations
title_short Development and validation of a GC-FID assay for determination of fluvastatin in pharmaceutical preparations
title_full Development and validation of a GC-FID assay for determination of fluvastatin in pharmaceutical preparations
title_fullStr Development and validation of a GC-FID assay for determination of fluvastatin in pharmaceutical preparations
title_full_unstemmed Development and validation of a GC-FID assay for determination of fluvastatin in pharmaceutical preparations
title_sort development and validation of a gc-fid assay for determination of fluvastatin in pharmaceutical preparations
publisher Sociedade Brasileira de Química
series Química Nova
issn 0100-4042
1678-7064
publishDate 2009-01-01
description A gas chromatographic method has been developed for the assay of fluvastatin sodium (FLU). FLU was silylated with N,O-bis(trimethylsilyl)trifluoroacetamide-1% trimethylchlorosilane at 90 ºC for 30 min and analysed in a DB-1 column by capillary gas chromatograph with a flame ionization detector. The method was validated. The assay was linear over the concentration range at 10.0 to 50.0 µg mL-1. The limit of detection and the limit of quantitation were 1.0 and 3.0 µg mL-1, respectively. The recoveries of FLU derivatives were in the range of 99.25-99.80%. In inter-day and intra-day analysis, the values of relative standard deviation (%) and the relative mean error (%) were found between 0.20-0.80% and -0.20-0.75%, respectively. The developed method was succesfully applied to analyze the FLU content in tablet formulation. The results were statistically compared with those obtained by the official method, and no significant difference was found between the two methods. Therefore, it can be recommended for the quality control assay of FLU in pharmaceutical industry.
topic fluvastatin
validation
pharmaceutical preparations
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422009000900021
work_keys_str_mv AT serapsaglikaslan developmentandvalidationofagcfidassayfordeterminationoffluvastatininpharmaceuticalpreparations
AT olcaysagirliandlaleersoy developmentandvalidationofagcfidassayfordeterminationoffluvastatininpharmaceuticalpreparations
_version_ 1725454419968917504